Florian Schmid
Net worth: - $ as of 2024-03-30
Network origin in Florian Schmid first degree
Entity | Entity type | Industry | |
---|---|---|---|
12
| Public Company | Biotechnology | 12 |
Public Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Florian Schmid via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | Pharmaceuticals: Major | Investor Relations Contact | |
FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Compliance Officer | |
4SC AG | Biotechnology | Chairman Chief Executive Officer | |
VERACYTE, INC. | Medical Specialties | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
MEDIGENE AG | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
MORPHOSYS AG | Biotechnology | Director of Finance/CFO Public Communications Contact | |
University of Freiburg | College/University | Undergraduate Degree | |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Fresenius ProServe GmbH
Fresenius ProServe GmbH Hospital/Nursing ManagementHealth Services Fresenius ProServe GmbH specializes in the medical business with hospitals and healthcare facilities. Its services range from the planning and construction of hospitals to technical and operational management in its core areas of hospital management and hospital engineering. The company is headquartered in Bad Homburg vor der Höhe, Germany. | Hospital/Nursing Management | Chief Executive Officer | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
Champlain College | College/University | Undergraduate Degree | |
Yale University | College/University | Doctorate Degree Undergraduate Degree | |
University of Michigan | College/University | Corporate Officer/Principal | |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director of Finance/CFO | |
The University of Sheffield | College/University | Doctorate Degree | |
University of Warwick | College/University | Masters Business Admin | |
University of Münster | College/University | Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
InflaRx GmbH
InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal | |
International Association for the Study of Lung Cancer | Corporate Officer/Principal | ||
Proteros biostructures GmbH
Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Director of Finance/CFO | |
BIONTECH SE | Biotechnology | Director of Finance/CFO | |
ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Investor Relations Contact | |
Hospitalia International GmbH
Hospitalia International GmbH Medical/Nursing ServicesHealth Services Part of Else Kröner-Fresenius-Stiftung, Hospitalia International GmbH is a German company that provides health care and other related services. The private company is based in Bad Homburg, Germany. The CEOs of the company are Mirsad Midzic, Jens K. Schäkel, Rafael Garcia Feil. | Medical/Nursing Services | Corporate Officer/Principal | |
DOMARK INTERNATIONAL INC | Miscellaneous Commercial Services | Investor Relations Contact | |
BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Fresenius Kabi Asia Pacific Ltd.
Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The private company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients. | Medical Distributors | Corporate Officer/Principal | |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member Chairman | |
George Washington University Law School | College/University | Graduate Degree | |
MIT Sloan School of Management | College/University | Masters Business Admin | |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cf Port GmbH | Founder | ||
Avery Dennison GmbH | Director of Finance/CFO | ||
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Medical/Nursing Services | Director/Board Member | |
BIOMX INC. | Biotechnology | Director/Board Member | |
IMMATICS N.V. | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Hospitalia Care Gmbh | Corporate Officer/Principal | ||
Fresenius Kabi Deutschland GmbH
Fresenius Kabi Deutschland GmbH Pharmaceuticals: GenericHealth Technology Part of Fresenius SE & Co. KGaA, Fresenius Kabi Deutschland GmbH is a healthcare company based in Bad Homburg vor der Hohe, Germany. The CEOs are Steffen Roser, Christoph Funke, Tanja Greve. Fresenius Kabi creates an environment of mutual respect, encouragement, and teamwork. The German company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The private company is also specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing & distribution set up. The company has summarized their expectations towards their suppliers and business partners in a suppliers code of conduct and a business partner code of conduct. The company was founded in 1999. | Pharmaceuticals: Generic | Chief Executive Officer | |
The Golf Championships, Inc. | Investor Relations Contact | ||
American Association For Cancer Research Foundation | Corporate Officer/Principal |
Statistics
International
Germany | 24 |
United States | 16 |
United Kingdom | 5 |
Switzerland | 3 |
Ireland | 2 |
Sectoral
Health Technology | 25 |
Consumer Services | 10 |
Health Services | 8 |
Finance | 3 |
Commercial Services | 2 |
Operational
Director/Board Member | 56 |
Corporate Officer/Principal | 37 |
Director of Finance/CFO | 22 |
Independent Dir/Board Member | 15 |
Chief Executive Officer | 15 |
Most connected contacts
Insiders | |
---|---|
Jörg Neermann | 34 |
Thomas Taapken | 16 |
Dinnies Johannes von der Osten | 16 |
Arnd Christ | 15 |
Jens Holstein | 14 |
Richard Brudnick | 13 |
Anthony Gibney | 11 |
Jason Marks | 11 |
Ulrich Dauer | 7 |
Bruce P. Burnett | 7 |
Jordan Silverstein | 7 |
Korinna Pilz | 5 |
Samir Shah | 4 |
Claudia Riedl | 3 |
Christian Schmid | 2 |
- Stock Market
- Insiders
- Florian Schmid
- Company connections